Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 1Polfa Tarchomin
02 1Antibiotice SA
03 3Ascent Innovative Medicines
04 7Atabay Group of Companies
05 3Avva Rus JSC
06 17Brooks laboratories Limited
07 1DEVATS INDIA
08 6DEVATS INDIA PRIVATE LTD
09 2Darou Pakhsh Pharma Chem Co
10 2Dr Seidel Life Science
11 1Embiotic Laboratories
12 1Flagship Biotech International Pvt. Ltd
13 3Hanlim Pharmaceutical
14 5Health Biotech
15 2IBN Savio
16 1InterMed
17 1KRUX Pharma
18 1Leeford Healthcare
19 23Medicef Pharma
20 2Myungmoon Pharm. Co., LTD.
21 7Neopharma
22 11Nishchem International Pvt. Ltd
23 1Orofino Pharmaceuticals Group
24 2RELIANCE FORMULATION PVT. LTD
25 2Smith & Kenner Pharmaceuticals
26 1Symbiosis Pharma
27 4Unichem Laboratories Limited
28 1Vaishali Pharma Ltd
29 2World Medicine
30 2ZRS LABS
31 11Blank
01 1Amoxicillin Anhydrous; Clavulanic Acid
02 2Amoxicillin Sodium; Clavulanic Acid
03 2Amoxicillin Trihydrate; Clavulanate Potassium
04 47Amoxicillin Trihydrate; Clavulanic Acid
05 1Amoxicillin; CLAVULANIC ACID POTASSIUM
06 14Amoxicillin; Clavulanate Potassium
07 35Amoxicillin; Clavulanic Acid
08 1Amoxycillin Trihydrate; Potassium Clavulanate
09 3Amoxycillin; Clavulanic Acid
10 2Cefixime; Clavulanate Potassium
11 4Cefixime; Clavulanic Acid
12 6Cefpodoxime Proxetil; Clavulanate Potassium
13 1Cefpodoxime; Clavulanic Acid
14 2Cefuroxime Axetil; Clavulanic Acid
15 4Clavulanic Acid
16 2Ticarcillin; Clavulanic Acid
01 6Dispersible Tablet
02 2Dry Syrup
03 1ER Tablet
04 5FC Tablet
05 2FILM COATED TABLET
06 4Film Coated Tablet
07 1Film Tablet
08 1Film-coated Tablet; Film-coated Tablet
09 1FilmTablet
10 5Injection
11 10OS
12 8Oral Suspension
13 2POWDER
14 1Pediatric Powder for Oral Suspension
15 4Powder for Oral Solution
16 7Powder for Oral Suspension
17 1Reconstituted syrup
18 1SYRUP
19 5Sachet
20 13Suspension
21 4TABLET
22 40Tablet
23 1Tablets
24 1Vial
25 1powder for injection/Infusion
01 11.7GM; 10ML
02 21000MG
03 21000MG; 125MG
04 11000MG; 200MG
05 21000MG; 62.5MG
06 1100MG; 12.5MG
07 1100MG; 62.5MG
08 21125MG
09 1125MG
10 1125MG/5ML; 31.25MG/5ML
11 1125MG; 31.25MG
12 1125MG; 31.5MG
13 1156.25MG
14 21:1
15 1200MG/5ML; 28.5MG/5ML
16 5200MG; 125MG
17 3200MG; 28.5MG
18 1228.5MG
19 1228.5MG; 5ML
20 1250MG
21 1250MG/5ML; 62.5MG/5ML
22 7250MG; 125MG
23 2250MG; 31.25MG
24 2250MG; 62.5MG
25 128.5MG/5ML
26 13.7G/30ML
27 1312.5MG
28 1375MG
29 13G; 100MG
30 1400MG/5ML; 57MG/5ML
31 4400MG; 57MG
32 140MG/ML; 5.7MG/ML
33 1437.5MG; 62.5MG
34 14500MG
35 1457MG
36 1500 MG ; 125 MG
37 1500MG
38 14500MG; 125MG
39 3500MG; 62.5MG
40 150MG; 12.5MG
41 150MG; 31.25MG
42 2562.5MG
43 1600MG/5ML; 42.9MG/5ML
44 2600MG; 42.9MG
45 1625MG
46 1800MG; 57MG
47 180MG; 11.4MG
48 15875MG; 125MG
49 26Blank
01 2Germany
02 94India
03 2Iran
04 3Italy
05 1Poland
06 1Romania
07 3Russia
08 5South Korea
09 9Turkey
10 7U.A.E
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Amoxicillin Trihydrate; Clavulanic Acid
Brand Name :
Dosage Form : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q3 2024
Amoxicillin Trihydrate; Clavulanic Acid
Dosage : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging : 80T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 80T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 500MG; 125MG
Packaging : 40T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 40T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 500MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Packaging : 50ml,10BTL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 50ml,10BTL
Regulatory Info : Generic
Dosage : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan Duo
Dosage Form : TABLET
Dosage Strength : 437.5MG; 62.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 437.5MG; 62.5MG
Brand Name : Amoclan Duo
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : Amoclan
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Brand Name :
Dosage Form : Suspension
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Packaging :
Regulatory Info : Generic ACTD Dossier- Available
Dosage : Suspension
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
